Octanate Lv (Human Coagulation Factor Viii)

Human Coagulation Factor VIII, the active ingredient in Octanate Lv, is a coagulation factor replacement therapy presented as a sterile solution for intravenous use. It is used to treat and prevent bleeding episodes in patients with hemophilia A, including children and adults.

GNH USA supplies Octanate Lv as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Octanate Lv is a recombinant factor VIII product that acts on the intrinsic pathway of the coagulation cascade to correct deficient clotting activity. - Hemophilia A (moderate to severe): Provides sustained factor VIII activity to control and prevent bleeding episodes. - Surgical prophylaxis in hemophilia A patients: Maintains hemostasis during operative procedures. - Peri‑operative peri‑operative per ​   t    t